Objective: To compare the national samples of patients who underwent isolated coronary artery bypass grafting (CABG) during the European System for Cardiac Operative Risk Evaluation (EuroSCORE) trial in order to evaluate national differences in epidemiology, patient risk pro®le and surgical methods. Methods: From September to November 1995, 11 731 patients had CABG in the six largest contributing nations to the EuroSCORE project: Germany, UK, Spain, Finland, France and Italy. The Chi-square and Kruskal±Wallis tests were applied to obtain an international comparison of patient general status, including pre-operative risk factors, cardiac status, critical preoperative states, rare conditions, urgency of surgery, angina status, coronary lesions, procedures and EuroSCORE risk assessment. Results: Large national samples (from 984 patients in Finland to 3138 in Germany) identi®ed signi®cant differences in epidemiology, risk pro®le and surgical practice. Regarding epidemiology, CABG accounted for 62.8% of adult cardiac surgery, with a range of 46.2 in Spain to 77.7% in Finland (P , 0:001). The mean age was 62.9 years (61.4 in Britain to 64.4 in France, P , 0:001). The mean body mass index was 26.8 (26 in France to 27.5 in Finland, P , 0:001). With regard to risk pro®le, diabetes was present in 20.3% of patients (11.8% in Britain to 27.7% in Spain, P , 0:001). Chronic renal failure was present in 8.3% (6.8% in Germany to 10.6% in Spain, P , 0:001). Chronic airway disease affected 3.8% (1.9% in Italy to 5.1% in Germany, P , 0:001). The mean ejection fraction was 0.56 (0.48 in Britain to 0.58 in Finland, P , 0:001). The mean predicted mortality (according to EuroSCORE) was 3.3% (2.8% in Finland to 3.6% in France, P , 0:001). The prevalence of chronic congestive heart failure, unstable angina and recent myocardial infarction also showed statistically signi®cant differences. No differences were found for some critical preoperative states (such as immediate preoperative cardiac massage and preoperative intubation), or for surgery for catheter laboratory complication. Regarding surgical practice, major differences were noted in preoperative intra-aortic balloon use (mean 1%, Finland 0%, Spain 2.3%, P , 0:001), the number of mammary artery conduits used (mean 0.9, Spain 0.7, France 1.1, P 0:0001) and the number of distal anastomoses (mean 3, France 2.7, Finland 3.8, P 0:001). Conclusion: There are important epidemiological differences in the national cohorts of CABG patients in the EuroSCORE database. Any international comparison of European surgical results must therefore take into account the risk pro®le of patients by using a compatible risk strati®cation system. q
Introduction
There may be differences in the characteristics and risk pro®les of patients undergoing coronary surgery in different European countries, as well as differences in surgical strategy and decision-making. We analyzed the European System for Cardiac Operative Risk Evaluation (Euro-SCORE) database to determine whether these differences exist and to quantify their extent.
Methods
The construction of the EuroSCORE database has been described [1] . Brie¯y, information on 68 preoperative risk factors, 29 operative variables and outcomes (survival) were collected in 128 voluntary participating centres from eight European countries during the period of September± November 1995. After double entry and submission to quality and completion checks, the database was used to identify risk factors for operative mortality in Europe. This study will focus on coronary surgery in Europe. The coronary surgery subset was de®ned as patients who underwent isolated coronary surgery excluding major concomitant procedures (aneurysmectomy, surgery for ventricular septal rupture, valve surgery, thoracic aortic surgery and congeni-tal cardiac surgery). Only operations performed using cardiopulmonary bypass were included in the database. Countries which contributed more than 500 isolated coronary artery bypass graft (CABG) patients to the EuroSCORE database were included in the study. National demographic, epidemiological and operative characteristics were compared using usual bivariate methods (the Chi-square test for categorical variables and the Kruskall±Wallis test for continuous variables). The risk pro®les of national coronary subsets, as determined by the mean EuroSCORE [2] , were compared using the Kruskall±Wallis test.
Results
Six European countries contributed more than 500 patients each to the EuroSCORE database. Coronary artery disease accounted for signi®cantly different proportions of the cardiac surgical population (Table 1 ). There were significant differences in the prevalence of general risk factors, such as age, body mass index, hypertension, diabetes, chronic renal failure and chronic airway disease (Table 2) . There were also signi®cant differences in cardiac status at the time of operation (Table 3) .
The mean overall risk scoring (according to EuroSCORE) differed signi®cantly between contributing countries, as a result of the different risk pro®les of the patients. These differences in casemix are detailed in Table 3 . There were, however, no signi®cant differences in the prevalence of critical preoperative states (such as immediate preoperative cardiac massage and pre-operative intubation), or for surgery for catheter laboratory complication. The analysis also highlighted major variations in surgical strategy for coronary disease, as evidenced by the rates of emergency surgery and preoperative intra-aortic balloon use, the number of mammary artery conduits used and the number of distal anastomoses (Table 4 ). The overall risk pro®le as assessed by EuroSCORE also differed signi®cantly between countries, as did the actual operative mortality (Table 5 ).
Discussion
This analysis shows that there are major differences in the risk pro®les of coronary patients in European countries and in the extent that coronary surgery contributes to the individual national cardiac surgical workload. There are also major differences in surgical strategy and decision making.
Many reasons can be put forward to account for the above differences. The epidemiology of ischaemic heart disease may differ signi®cantly between countries. This may be related to hereditary factors, or to a variation in lifestyle and living standards with different diets, smoking history, alcohol consumption, and so on. Another reason may be found in the severity of cardiac disease and comorbidity in patients presenting for operation. This may be derived from differences in the risk pro®le of the population as a whole, or it may arise as a result of the impact of resource availability for coronary revascularization; the more limited the resources, the longer the waiting times and the more advanced the state of disease at the time of presentation to the surgeon. The UK, for example, has relatively fewer resources for coronary surgery in comparison with other northern European countries. It is interesting to note that surgery within 90 days of a myocardial infarct is relatively rare in the UK, presumably because of the more limited access to angiographic facilities. Finally, we highlighted differences which are likely to be more related to surgical decision making than to the risk pro®le of the patient, although the latter undoubtedly plays a part. Major differences in the use of the internal mammary artery as a conduit, in preoperative intra-aortic balloon use, and in the number of distal anastomoses are likely to be in¯uenced by the prevalent surgical culture.
One interesting feature is the consistently higher risk pro®le on patients in some parts of southern Europe (France and Spain), and this is mirrored by a higher procedural mortality in coronary surgery. On the other hand, the exceptionally low surgical mortality rate in Finland is associated with a relatively low-risk cardiac surgical population as assessed by EuroSCORE. Whatever the causes of the differences that we identi®ed, it is clear that there is signi®cant variation in patients, risk pro®le and surgical strategy in Europe. It is therefore not suf®cient to assess the quality of care in European cardiac surgery by measuring crude procedural mortality alone.
One limitation of this study is the voluntary nature of centre recruitment in the EuroSCORE project. Such selfselection may introduce a bias towards centres that support open audit and assessment and, by implication, those whose results may better withstand close scrutiny. This limitation is partly addressed by the guaranteed patient, surgeon and centre con®dentiality provided by the project organizers.
This study shows that international comparisons of operative mortality rates in Europe are meaningless without risk adjustments derived from casemix. The use of an appropriate risk strati®cation system which is compatible with European cardiac surgery would allow better comparison and more meaningful assessment of the quality of surgical care, provided that the system is applicable and has good discriminatory powers in individual European countries. Further analysis is needed to determine whether Euro-SCORE satis®es these requirements. represented a very large proportion of what happened in these countries during the three months, it was on a voluntary enrolment basis; for example, we have 100% of the operations in Scotland but only about 50 or 60% of the operations in Germany. So it would be a little bit dif®cult to carry out that sort of assessment.
Dr P. Sergeant (Leuven, Belgium): Could some of the differences be due to variable interpretation or to treatment variability? Dr Nashef: I think it would be very dif®cult. If you saw the de®nitions that were given for the risk factors in the EuroSCORE data collection project, these de®nitions were very tight indeed, and the de®nitions were there at the point of data collection, so that it really allowed no ambiguity as to whether something would or would not feature as a factor.
Dr Sergeant: Has there been some active auditing or process control, validation after?
Dr Nashef: No. One of the limitations of this study is that there was no on-site validation, as you know.
Dr W. Brenner (Hackensack, NJ, USA): In the US, in the interest of consumer education, the publication of mortality data in newspapers and other media sources under the guise of allowing the consumers to make a better choice has resulted in denial of open heart surgery to high risk categories. As publication of data like this becomes more prevalent around the world, I am concerned that it becomes a game of`gaming the system', comparing heterogeneous populations with homogenous populations. I wonder if we are really heading anywhere meaningful.
Dr Nashef: This is clearly one of the largest debates that we as cardiac surgeons will have to face in the next few years, and it has already happened in the US, it is beginning to happen in the UK, and I am sure that the rest of Europe will follow. I cannot really address that particular issue in this presentation, but it is important that, if we are going to risk-stratify, our system should be compatible with the population that we are looking at, and this issue will be dealt with by my collaborator on Wednesday.
Dr Sergeant: I think that the larger institutions in Europe, University
Teaching Centers, or similar, should publish their risk pro®les as well as their results. In our own institution, the average EuroSCORE predicted risk is 6%. Patient pro®les can similarly vary from institution to institution as they vary between countries. Dr R. Stanbridge (London, UK): I wondered if there was a sort of gross error check here, because I noticed that the ®gures for the UK for diabetes and hypertension seemed much lower than I would expect from our usual clinical practice, and I wondered if you had compared those ®gures with the practice that you have in Cambridge to see whether there is perhaps a big sampling error here or not?
Dr Nashef: The ®gures were compatible with what we have seen in Cambridge, and I think that perhaps if you look at your own ®gures you might ®nd that they are not far off.
Dr F. Grover (Denver, CO, USA): This is really interesting data and it is interesting to see the different risk pro®ling from country to country. The US is more homogenous, I think, but then STS is also performing data analysis at some state and regional levels. We have found, in several, that our national risk coef®cient is very close to regional risk coef®cients, and can therefore be utilized for the state and regional analyses. There may be subtle differences in the prevalence of certain risk factors in different regions, but the weight of those risk factors on mortality may still be the same.
It would be interesting for you to calculate risk coef®cients for each country eventually and do a risk algorithm for that country, utilize it for estimating the operative mortality using that risk algorithm, and then compare the results to those obtained from the risk coef®cient that is derived from the data from all countries.
It may be that the single country and multi country risk models are very similar but the incidence of the various risk factors varies from country to country. The single risk coef®cient may still produce an accurate estimate of your operative mortality. This is fascinating work and I appreciate your bringing it to our attention.
